CSF N- and O- Glycomics and Glycoproteomics
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 8326
Special Issue Editor
Interests: glycomics; mass spectrometry; polysaccharides; lipopolysaccharides; structural elucidation; congenital glycosylation defects; neurodegenerative diseases
Special Issue Information
Dear Colleagues,
Cerebrospinal fluid (CSF) is an exceptionally fascinating matrix for the study of neurodegeneration, since it has direct contact with the brain and the spinal cord and biochemical changes occurring during disease progression can be disclosed in the cerebrospinal fluid. Therefore, CSF glycomics and glycoproteomics together represent a reliable and feasible approach for the characterization of the brain glycoproteome, enabling the identification of possible alterations on different pathological processes affecting the central nervous system.
Glycosylation changes in Alzheimer’s disease, leukodystrophies, GM2 gangliosidosis, schizophrenia, and other diseases have been recently reported. This Special Issue aims to obtain a global view on the state of N- and O-glycosylation for the discovery of neurodegeneration biomarkers and/or potential pharmaceutical targets.
Dr. Domenico Garozzo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cerebrospinal fluid (CSF)
- glycomics
- glycoproteomics
- neurodegeneration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.